Farmpharma
Farmpharma develops interferon-based veterinary products that provide both treatment and prevention of viral and bacterial infections in livestock. By significantly reducing the reliance on antibiotics, these products enhance animal health and promote sustainable practices in the livestock industry.
- Agriculture Technology
- Biotechnology
Funding
Raised to date
$81.9KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Viral and bacterial infections pose a significant threat to livestock health, often requiring antibiotic treatments. Over-reliance on antibiotics in livestock can lead to antimicrobial resistance, impacting both animal and human health, and raising concerns about sustainable farming practices.
Solution
Farmpharma develops species-specific interferon-based veterinary products designed for both the treatment and prevention of viral and bacterial infections in livestock. These products stimulate the animal's immune system, offering a proactive approach to disease management and reducing the need for antibiotics. By providing an alternative to traditional antibiotic treatments, Farmpharma aims to improve animal health, promote sustainable livestock farming, and mitigate the risk of antimicrobial resistance. The company's products are positioned as a novel immunotherapy solution within the livestock industry.
Target Audience
Farmpharma's primary customers are livestock farmers and veterinarians seeking effective alternatives to antibiotics for managing viral and bacterial infections in animals.
Features
- Species-specific interferon formulation to maximize efficacy and minimize side effects.
- Dual-action products for both treatment of existing infections and prevention of future outbreaks.
- Reduction of antibiotic usage in livestock farming.
- Stimulation of the animal's innate immune system.